Preparation and Biodistribution of Re-188-Sulfur Colloid Suspension in Lipiodol
![]() |
Kim, Young-Ju
(Department of Nuclear Medicine, Seoul National University College of Medicine)
Jeong, Jae-Min (Department of Nuclear Medicine, Seoul National University College of Medicine) Kim, Seok-Ki (Department of Nuclear Medicine, National Cancer Center) Son, Mi-Won (Research Laboratories, Dong-A Pharm. Co., Ltd.) Lee, Dong-Soo (Department of Nuclear Medicine, Seoul National University College of Medicine) Chung, June-Key (Department of Nuclear Medicine, Seoul National University College of Medicine) Lee, Myung-Chul (Department of Nuclear Medicine, Seoul National University College of Medicine) |
1 | Lencieoni R, Vignali C, Caramella D, Cioni R, Mazzeo S, Bartolozzi C. Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 1994;17:70-5 |
2 | Park CH, Yoo HS, Lee JT, Kim DI. Iodine-131-labeled lipiodol retention within hepatic cavernous hemangioma. Radiology 1987;163: 283-4 DOI PUBMED |
3 | Chen MN, Wang SJ, Kao CH, Tsai ZT. A column method for lipiodol labeling with yttrium-90 [abstract]. J Nucl Med 1994;35: 241p |
4 | Yu J, Hafeli UO, Sands M, Dong Y. 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer. Appl Radiat Isot 2003;58: 567-73 DOI ScienceOn |
5 | Lee Y-S, Jeong JM, Kim YJ, Chung JW, Park JH, Suh Y-G, et al. Sythesis of 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Nucl Med Commun 2002;23: 237-42 DOI ScienceOn |
6 | Wang S-J, Lin W-Y, Chen M-N, Hsieh B-T, Shen L-H, Tsai Z-T, et al. Radiolabeling of lipiodol with generator-produced 188Re for hepartic tumor therapy. Appl Radiat Isot 1996;47: 267-71 DOI ScienceOn |
7 | Madsen MT, Park CH, Takur ML. Dosimetry of iodine-131 ethiodol in the treatment of hepatoma, J Nucl Med 1988;29: 1038-44 PUBMED |
8 |
Jeong JM, Kim YJ, Lee YS, Ko JI,, Son M, Lee DS, et al. Lipiodol solution of a lipiodol agent, |
9 | Nakajo M, Kobayashi H, Shimabukuro K, Shirono K, Sakata H, Taguchi M, et al. Biodistribution and in vivo kinetics of iodine-131 lipiodol infused via the hepatic artery of patients with hepatic cancer. J Nucl Med 1988;29: 1066-77 PUBMED |
10 | Wang S-J, Lin W-Y, Hsieh B-T, Shen L-H, Tsai Z-T, Ting G, et al. Rhenium-188 sulphur colloid as a radiation synovectomy agent. Eur J Nucl Med 1995;22: 505-7 DOI PUBMED ScienceOn |
11 | Trinchet J-C, Rached AA, Beaugrand M, Mathieu D, Cheveret S, Chastang C. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. New Engl J Med 1995;332: 1256-61 DOI ScienceOn |
12 | Wang S-J, Lin W-Y, Chen M-N, Shen L-H, Tsai Z-T, Ting G. Preparation and biodistribution of yttrium-90 lipiodol in rats following hepartic arterial injection. Eur J Nucl Med 1995;22: 233-6 DOI ScienceOn |
13 | Venkatesan PP, Shorkroff S, Zalutsky MR, Sledge CB. Rhenium heptasulfide: a potential carrier system for radiation synovectomy. Nucl Med Biol 1990;17: 357-62 |
14 | Kim YJ, Jeong JM, Chang YS, Lee YJ, Lee DS Chung J-K, et al. Preparation and biodistribution of Re-188 sulfur colloid, Koraen J Nucl Med 1998;32:298-304 |
15 | Wang S-J, Lin W-Y, Chen M-N, Hsieh B-T, Shen L-H, Tsai Z-T, et al. Biodistribution of rhenium-188 lipiodol infused via the hepatic artery of rats with hepatic tumours. Eur J Nucl Med 1996;23: 13-7 DOI ScienceOn |
16 | Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989;170: 783-6 PUBMED |
17 | Park CH, Suh JH, Yoo HS. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Clin Nucl Med 1986;11:514-7 DOI PUBMED |
18 | Yoo HS, Suh JH, Lee JT, Kim DI, Park CY, Kim BS, et al. Therapeutic feasibility study and clinical trial of intrahepatic I-131-lipiodol on patients with hepatocellular carcinoma. Korean J Nucl Med 1986;20: 61-71 |
![]() |